Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Sovereign AI Market to Reach USD 148.0 Billion by 2032, Growing at 20.6% CAGR, Says MarketsandMarkets™

GlobeNewswire

Delray Beach, FL, Aug. 19, 2026 -- The global sovereign AI market is set for rapid expansion, climbing from an estimated USD 40.0 billion in 2025 to USD 148.0 billion by 2032, a compound annual growth rate of 20.6% between 2026 and 2032, according to a new report from MarketsandMarkets. The growth reflects a fundamental shift in how governments and enterprises approach artificial intelligence: no longer treated purely as a productivity tool, AI is increasingly viewed as a strategic national asset requiring domestic control over data, models, infrastructure, and governance. From the European Union's AI Act to India's National AI Mission and the Gulf states' multibillion-dollar sovereign AI programs, the drive to build and own AI capability — rather than rent it from foreign providers — is reshaping government procurement, infrastructure investment, and geopolitical strategy worldwide.

  1. AutomotiveJETOUR Connects Its Travel+ Vision with Chery’s Commitment to a Greener FutureCompanies: CheryAs global mobility evolves, sustainability is becoming an increasingly important part of travel. Through its Travel+ strategy, JETOUR connects mobility with diverse travel scenarios and lifestyle needs. This vision aligns with Chery Group’s efforts to promote green mobility, environmental awareness and sustainable development.
  2. AutomotiveJETOUR Connects Technology with Real-World Travel as Chery Expands InnovationCompanies: CheryAs global mobility evolves, technology is opening new possibilities for travel, intelligent transportation and sustainable development. For JETOUR, this direction supports its Travel+ strategy, connecting vehicles with broader travel experiences and lifestyle needs.
  3. AIFrom Physical AI to Scaled Deployment: WeRide Named Among WICV 2026's Top 10 Automotive AI Application CasesWeRide has been named among the "Top 10 Automotive AI Application Cases of 2026" at the 2026 World Intelligent Connected Vehicles Conference (WICV).
  4. HealthcareSuper Vision Technology: World’s first i-NYS implant for congenital nystagmus in a Chinese boyA 9-year-old boy has become the world's first patient to receive a newly approved implant to treat congenital nystagmus, in a procedure performed at Peking University People's Hospital. This marks that the technology has moved from regulatory clearance to clinical practice.
  5. Government & policyEuropean Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapseCompanies: Johnson & JohnsonJohnson & Johnson, a worldwide leader in multiple myeloma, today announced that the European Commission (EC) has approved an indication extension of TECVAYLI® (teclistamab) for the treatment of adult patients with relapsed/refractory multiple myeloma (RRMM) who have received at least one prior therapy. Building on the recent EC approval of teclistamab plus daratumumab, this indication extension introduces teclistamab monotherapy as an additional second-line treatment option for patients living with RRMM and reinforces the wider potential of teclistamab across both monotherapy and combination approaches for patients at first relapse.1,2
  6. FinanceGix Internet Shares to Trade Exclusively on NasdaqVoluntary Delisting of Ordinary Shares from Trading on the Tel Aviv Stock Exchange to Promote U.S.-Based Trading, Reduce Administrative Costs of Dual Listing